| Donald J Paquet, MD | |
|
6424 E Broadway Rd Ste 101, Mesa, AZ 85206-1750 | |
| (480) 456-9000 | |
| Not Available |
| Full Name | Donald J Paquet |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 6424 E Broadway Rd Ste 101, Mesa, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801885686 | NPI | - | NPPES |
| 289472 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 18812 (Arizona) | Primary |
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
Gene therapy is a kind of experimental treatment that is designed to fix faulty genetic material and help a patient fight off or recover from a disease.
The Texas A&M University System's workers' compensation pharmacy benefit management strategy with Tampa, FL based myMatrixx, which integrates clinical pharmacy services with advanced technology to optimize recovery outcomes, features a collaborative connectivity arrangement assuring continuation of the Texas A&M System's compliance with state eBilling requirements.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Doctors have known for a long time that blood pressure is one measure of an individual's health. This research is the first to demonstrate that there a connection between nations' happiness and blood-pressure levels.
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the Company has been selected to present key Tovaxin data at the upcoming American Academy of Neurology 63rd Annual Meeting to be held in Honolulu, Hawaii April 9-16, 2011.
› Verified 2 days ago
| Entity Name | Southwest Diagnostic Imaging Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902896236 PECOS PAC ID: 7416946199 Enrollment ID: O20040507001294 |
News Archive
Gene therapy is a kind of experimental treatment that is designed to fix faulty genetic material and help a patient fight off or recover from a disease.
The Texas A&M University System's workers' compensation pharmacy benefit management strategy with Tampa, FL based myMatrixx, which integrates clinical pharmacy services with advanced technology to optimize recovery outcomes, features a collaborative connectivity arrangement assuring continuation of the Texas A&M System's compliance with state eBilling requirements.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Doctors have known for a long time that blood pressure is one measure of an individual's health. This research is the first to demonstrate that there a connection between nations' happiness and blood-pressure levels.
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the Company has been selected to present key Tovaxin data at the upcoming American Academy of Neurology 63rd Annual Meeting to be held in Honolulu, Hawaii April 9-16, 2011.
› Verified 2 days ago
| Entity Name | Associated Valley Radiologists Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932683257 PECOS PAC ID: 8325388499 Enrollment ID: O20190327003225 |
News Archive
Gene therapy is a kind of experimental treatment that is designed to fix faulty genetic material and help a patient fight off or recover from a disease.
The Texas A&M University System's workers' compensation pharmacy benefit management strategy with Tampa, FL based myMatrixx, which integrates clinical pharmacy services with advanced technology to optimize recovery outcomes, features a collaborative connectivity arrangement assuring continuation of the Texas A&M System's compliance with state eBilling requirements.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Doctors have known for a long time that blood pressure is one measure of an individual's health. This research is the first to demonstrate that there a connection between nations' happiness and blood-pressure levels.
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the Company has been selected to present key Tovaxin data at the upcoming American Academy of Neurology 63rd Annual Meeting to be held in Honolulu, Hawaii April 9-16, 2011.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald J Paquet, MD 1201 S Alma School Rd, Suite 14000, Mesa, AZ 85210-2008 Ph: (480) 545-8119 | Donald J Paquet, MD 6424 E Broadway Rd Ste 101, Mesa, AZ 85206-1750 Ph: (480) 456-9000 |
News Archive
Gene therapy is a kind of experimental treatment that is designed to fix faulty genetic material and help a patient fight off or recover from a disease.
The Texas A&M University System's workers' compensation pharmacy benefit management strategy with Tampa, FL based myMatrixx, which integrates clinical pharmacy services with advanced technology to optimize recovery outcomes, features a collaborative connectivity arrangement assuring continuation of the Texas A&M System's compliance with state eBilling requirements.
PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.
Doctors have known for a long time that blood pressure is one measure of an individual's health. This research is the first to demonstrate that there a connection between nations' happiness and blood-pressure levels.
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis, announced today that the Company has been selected to present key Tovaxin data at the upcoming American Academy of Neurology 63rd Annual Meeting to be held in Honolulu, Hawaii April 9-16, 2011.
› Verified 2 days ago
Asim A. Khwaja, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1125 E Southern Ave, Suite 300, Mesa, AZ 85204 Phone: 480-545-8119 Fax: 480-926-8332 | |
Tobias Schifter, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd Ste 101, Mesa, AZ 85206 Phone: 480-456-9000 | |
Stuart B. Cohen, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1125 E Southern Ave, Suite 300, Mesa, AZ 85204 Phone: 480-545-8119 Fax: 480-892-6805 | |
James B. Lyons, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd Ste 101, Mesa, AZ 85206 Phone: 480-456-9000 | |
Dr. Kirk D Minkus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7529 E Broadway Rd Ste 101, Mesa, AZ 85208 Phone: 480-945-4343 Fax: 480-945-4350 | |
Marvin K. Tam, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd Ste 101, Mesa, AZ 85206 Phone: 480-456-9000 | |
Brian J. Igel, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1125 E Southern Ave, Suite 300, Mesa, AZ 85204 Phone: 480-545-8119 Fax: 480-892-6805 |